pål klepstad
pål klepstad
Norwegian University of Technology and Science
Verified email at
Cited by
Cited by
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC
A Caraceni, G Hanks, S Kaasa, MI Bennett, C Brunelli, N Cherny, O Dale, ...
The lancet oncology 13 (2), e58-e68, 2012
The 118 A> G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
P Klepstad, TT Rakvåg, S Kaasa, M Holthe, O Dale, PC Borchgrevink, ...
Acta Anaesthesiologica Scandinavica 48 (10), 1232-1239, 2004
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients
TT Rakvåg, P Klepstad, C Baar, TM Kvam, O Dale, S Kaasa, HE Krokan, ...
Pain 116 (1-2), 73-78, 2005
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene
CC Reyes-Gibby, S Shete, T Rakvåg, SV Bhat, F Skorpen, E Bruera, ...
Pain 130 (1-2), 25-30, 2007
Health care providers underestimate symptom intensities of cancer patients: a multicenter European study
EA Laugsand, MAG Sprangers, K Bjordal, F Skorpen, S Kaasa, ...
Health and quality of life outcomes 8 (1), 1-13, 2010
The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients
P Klepstad, JH Loge, PC Borchgrevink, TR Mendoza, CS Cleeland, ...
Journal of pain and symptom management 24 (5), 517-525, 2002
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients
P Klepstad, T Fladvad, F Skorpen, K Bjordal, A Caraceni, O Dale, ...
Pain 152 (5), 1139-1145, 2011
Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial
Ø Paulsen, P Klepstad, JH Rosland, N Aass, E Albert, P Fayers, S Kaasa
Journal of clinical oncology 32 (29), 3221-3228, 2014
Evidence of a role for NMDA receptors in pain perception
P Klepstad, A Maurset, ER Moberg, I Øye
European journal of pharmacology 187 (3), 513-518, 1990
Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system
BJ Laird, S Kaasa, DC McMillan, MT Fallon, MJ Hjermstad, P Fayers, ...
Clinical Cancer Research 19 (19), 5456-5464, 2013
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to …
M Holthe, TN Rakvåg, P Klepstad, JR Idle, S Kaasa, HE Krokan, ...
The pharmacogenomics journal 3 (1), 17-26, 2003
Genetic Variation in the Catechol-O-Methyltransferase (COMT) Gene and Morphine Requirements in Cancer Patients with Pain
TT Rakvåg, JR Ross, H Sato, F Skorpen, S Kaasa, P Klepstad
Molecular pain 4, 1744-8069-4-64, 2008
Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network
P Klepstad, S Kaasa, N Cherny, G Hanks, F De Conno, ...
Palliative medicine 19 (6), 477-484, 2005
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine …
M Holthe, P Klepstad, K Zahlsen, PC Borchgrevink, L Hagen, O Dale, ...
European journal of clinical pharmacology 58, 353-356, 2002
Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response
BJA Laird, M Fallon, MJ Hjermstad, S Tuck, S Kaasa, P Klepstad, ...
Journal of Clinical Oncology 34 (23), 2769, 2016
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer
BJ Laird, DC McMillan, P Fayers, K Fearon, S Kaasa, MT Fallon, ...
The oncologist 18 (9), 1050-1055, 2013
Severe head injury: control of physiological variables, organ failure and complications in the intensive care unit
K Schirmer‐Mikalsen, A Vik, SE Gisvold, T Skandsen, H Hynne, ...
Acta Anaesthesiologica Scandinavica 51 (9), 1194-1201, 2007
Immediate-or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial
P Klepstad, S Kaasa, Å Jystad, B Hval, PC Borchgrevink
Pain 101 (1-2), 193-198, 2003
for the European Palliative Care Research Collaborative (EPCRC) on behalf of the European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of …
A Caraceni, G Hanks, S Kaasa, MI Bennett, C Brunelli, N Cherny, O Dale, ...
Lancet Oncol 13 (2), e58-e68, 2012
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
TN Andreassen, I Eftedal, P Klepstad, A Davies, K Bjordal, S Lundström, ...
European journal of clinical pharmacology 68, 55-64, 2012
The system can't perform the operation now. Try again later.
Articles 1–20